Average Insider

Where insiders trade, we follow

$PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Healthcare
Sector
Medical - Instruments & Supplies
Industry
Paul Arthur LaViolette
CEO
75
Employees
$21.57
Current Price
$1.60B
Market Cap
52W Low$12.56
Current$21.5765.6% above low, 34.4% below high
52W High$26.30

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00--All Sells
Sells17$2,932,200.00125,000
3 monthsBuys00--All Sells
Sells17$2,932,200.00125,000
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Feb 18, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale5,000$23.64$118,200.00View Details
Feb 12, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$23.37$467,400.00View Details
Feb 17, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$23.63$472,600.00View Details
Feb 13, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$23.53$470,600.00View Details
Feb 9, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$21.45$429,000.00View Details
Feb 11, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$25.20$504,000.00View Details
Feb 10, 2026
Danahy Kevin Patrick
Chief Commercial Officer
Sale20,000$23.52$470,400.00View Details
11 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Feb 19, 2026
EPS
Estimated-$0.32
ActualN/A
Revenue
Estimated$250.00K
ActualN/A

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.3.23